patients with chronic myelogenous leukaemia ( cml ) in untreated chronic phase are deficient in their ability to generate lymphokine-activated killer ( lak ) cells from peripheral blood mononuclear cells although they possess essentially normal levels of cd16+ and leu19+ lymphocytes , which do not seem to be actively suppressed by tumour cells .
C0023473
chronic myelogenous leukaemia
C0024264
lymphocytes